DOI: 10.1128/AAC.00393-19
Article Information
PubMed
Published By
History
- Received February 22, 2019
- Returned for modification March 20, 2019
- Accepted May 21, 2019
- Published online July 25, 2019.
Copyright & Usage
Copyright © 2019 American Society for Microbiology. All Rights Reserved.
Article Versions
- Accepted Manuscript version (June 03, 2019).
- You are viewing the most recent version of this article.
Author Information
- Aurélie Velaya,b,d,
- Morgane Solisa,b,d,
- Ilies Benotmaneb,c,d,
- Pierre Gantnera,b,d,
- Eric Souliera,b,d,
- Bruno Moulinb,c,d,
- Sophie Caillardb,c,d and
- Samira Fafi-Kremera,b,d
- aVirology Laboratory, Strasbourg University Hospital, Strasbourg, France
- bStrasbourg University, INSERM, IRM UMR-S 1109, Strasbourg, France
- cNephrology Department, Strasbourg University Hospital, Strasbourg, France
- dFédération de Médecine Translationnelle de Strasbourg (FMTS), Strasbourg, France
- Address correspondence to Samira Fafi-Kremer, samira.fafi-kremer{at}unistra.fr.
Citation Velay A, Solis M, Benotmane I, Gantner P, Soulier E, Moulin B, Caillard S, Fafi-Kremer S. 2019. Intravenous immunoglobulin administration significantly increases BKPyV genotype-specific neutralizing antibody titers in kidney transplant recipients. Antimicrob Agents Chemother 63:e00393-19. https://doi.org/10.1128/AAC.00393-19.
